LRP1 and Alzheimer disease: Although evidences about therapeutic effects of proangiogenic pathway, Wnt/β catenin pathway, MMPs‐mediated BBB dissociation even P‐gp or LRP‐1 mediated Aβ clearance in AD treatment are rare, their important roles in treating other neurodegenerative diseases implies great potentials in AD treatment.